Banaschewski, T. (2018). Growth and puberty in a 2-year open-label study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder. CNS drugs, 32(5), . https://doi.org/10.1007/s40263-018-0514-8
Chicago Style (17th ed.) CitationBanaschewski, Tobias. "Growth and Puberty in a 2-year Open-label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-deficit/hyperactivity Disorder." CNS Drugs 32, no. 5 (2018). https://doi.org/10.1007/s40263-018-0514-8.
MLA (9th ed.) CitationBanaschewski, Tobias. "Growth and Puberty in a 2-year Open-label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-deficit/hyperactivity Disorder." CNS Drugs, vol. 32, no. 5, 2018, https://doi.org/10.1007/s40263-018-0514-8.